29.11.2017 15:10:00
|
Revel Secures Growth Equity Investment from TT Capital Partners to Accelerate Market Expansion
MINNEAPOLIS, Nov. 29, 2017 /PRNewswire/ -- Revel, a leading health engagement company, announced today it has secured a growth equity investment of over $17 million from TT Capital Partners ("TTCP"). The investment will accelerate Revel's expansion into new target markets and advance the innovation and technology development for Revel Connect, the industry's leading health engagement platform. Revel is known for its unique ability to engage health insurance members in their own healthcare, enabling the healthcare system to support the individual, deliver better health outcomes and reduce unnecessary costs.
"This investment recognizes not only our success to date, but also our position as a leader in the marketplace," said Jeff Fritz, CEO of Revel. "We'll be able to grow our sales, marketing, and technology organizations and add momentum to keep Revel Connect ahead of the industry curve. I'm looking forward to working closely with the team at TTCP as we continue to drive better results for plans, providers and healthcare consumers as a whole."
As the healthcare industry continues to focus more on quality and outcomes, and the shift to value-based care continues, the healthcare ecosystem needs new capabilities that drive engagement, accelerate efficiency and improve outcomes. Helping health insurance members and healthcare patients engage in their healthcare is critical to improving health outcomes. In addition, data analytics is driving richer, more secure, and interoperable patient information.
Revel's innovative technology provides strong integration for greater efficiency while creating personalized experiences to support more meaningful connections. Revel Connect delivers powerful health engagement, yielding a strong foundation of actionable data, improving experiences with members and patients, and resulting in healthcare campaigns that create stronger results and lower costs.
"Revel has demonstrated a unique ability to engage health insurance members in their own healthcare, addressing an important need as the healthcare industry continues to focus more on quality and better outcomes," said Conor Green, Partner at TTCP. "We are eager to collaborate with the management team as Revel continues to serve its existing customers, expand into new markets and accelerate further development of its modern technology platform."
About Revel
Revel is a healthcare technology company that is rethinking and reinventing health engagement and making it better through its industry leading platform, Revel Connect. Revel continuously finds new ways to improve healthcare member and patient experiences, drive better health outcomes and redefine what's possible. Learn more at Revel-Health.com
Follow Revel on Twitter and connect with us on LinkedIn. Learn more about who we are and our approach by visiting us at Revel-Health.com
About TT Capital Partners
TT Capital Partners (TTCP) is a healthcare principal investor, collaborating with healthcare technology and services companies that have the potential be become market leaders. Leveraging the insights garnered from a unique knowledge-based platform, TTCP has invested in some of the most innovative, high-growth businesses in healthcare. TTCP is part of an independent healthcare merchant bank. For more, visit TTCapitalPartners.com.
View original content:http://www.prnewswire.com/news-releases/revel-secures-growth-equity-investment-from-tt-capital-partners-to-accelerate-market-expansion-300563187.html
SOURCE Revel

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Apple Inc.mehr Nachrichten
22:35 |
Schwacher Handel: NASDAQ Composite fällt zum Handelsende (finanzen.at) | |
22:35 |
Donnerstagshandel in New York: S&P 500 legt zum Handelsende den Rückwärtsgang ein (finanzen.at) | |
22:35 |
Börse New York: NASDAQ 100 schlussendlich in Rot (finanzen.at) | |
20:05 |
NASDAQ Composite-Handel aktuell: NASDAQ Composite legt am Donnerstagnachmittag den Rückwärtsgang ein (finanzen.at) | |
20:05 |
Angespannte Stimmung in New York: So bewegt sich der S&P 500 am Nachmittag (finanzen.at) | |
20:05 |
Anleger in New York halten sich zurück: NASDAQ 100 gibt am Donnerstagnachmittag nach (finanzen.at) | |
20:05 |
Anleger in New York halten sich zurück: Dow Jones verliert (finanzen.at) | |
18:03 |
Dow Jones-Handel aktuell: Dow Jones notiert im Minus (finanzen.at) |
Analysen zu Apple Inc.mehr Analysen
10:02 | Apple Buy | Goldman Sachs Group Inc. | |
19.02.25 | Apple Neutral | UBS AG | |
17.02.25 | Apple Neutral | UBS AG | |
17.02.25 | Apple Buy | Goldman Sachs Group Inc. | |
04.02.25 | Apple Neutral | UBS AG |
Aktien in diesem Artikel
Apple Inc. | 233,90 | -0,43% |
|
Humana Inc. | 255,30 | 1,07% |
|